» Authors » Toshihiko Yoshida

Toshihiko Yoshida

Explore the profile of Toshihiko Yoshida including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 708
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gon H, Komatsu S, Soyama H, Tanaka M, Kido M, Fukushima K, et al.
Langenbecks Arch Surg . 2025 Jan; 410(1):37. PMID: 39804508
Purpose: The impact of body-cavity depth on open (OLR) and laparoscopic liver resection (LLR) of segment 7 remains unclear. Therefore, we investigated the influence of body-cavity depth at the upper-right...
2.
Ishihara N, Komatsu S, Yano Y, Fujishima Y, Ishida J, Kido M, et al.
Anticancer Res . 2024 Dec; 45(1):251-260. PMID: 39740814
Background/aim: Atezolizumab plus bevacizumab (AteBev) is widely used as a first-line treatment for advanced hepatocellular carcinoma (HCC). However, evidence regarding the optimal drug sequence following AteBev treatment is limited. This...
3.
Sakai S, Mitsui Y, Miyamoto A, Higuchi K, Yoshida T, Hara K, et al.
J Shoulder Elbow Surg . 2024 Oct; PMID: 39369947
Background: Focused extracorporeal shock wave therapy (FSWT) is effective for treating calcific tendinitis of the shoulder. However, only a few reports exist on the factors related to calcium resorption after...
4.
Oji K, Urade T, Kido M, Komatsu S, Gon H, Yamasaki N, et al.
Langenbecks Arch Surg . 2024 Aug; 409(1):243. PMID: 39110230
Purpose: The technical difficulties of laparoscopic liver resection (LLR) are greatly associated with the location of liver tumors. Since segment 8 (S8) contains a wide area, the difficulty of LLR...
5.
Gon H, Komatsu S, Soyama H, Tanaka M, Fukushima K, Urade T, et al.
Langenbecks Arch Surg . 2024 Jul; 409(1):233. PMID: 39078441
Purpose: The impact of postoperative bile leak on the prognosis of patients with hepatocellular carcinoma who underwent liver resection is controversial. This study aimed to investigate the prognostic impact of...
6.
Ishihara N, Komatsu S, Kido M, Gon H, Fukushima K, Urade T, et al.
Oncol Lett . 2024 May; 28(1):332. PMID: 38807678
Tremelimumab plus durvalumab (Dur/Tre) is the first-line treatment for advanced hepatocellular carcinoma (HCC) worldwide. The present report describes the case of a 68-year-old man diagnosed with advanced HCC and a...
7.
Gon H, Komatsu S, Omiya S, Kido M, Fukushima K, Urade T, et al.
Anticancer Res . 2024 Apr; 44(5):2031-2038. PMID: 38677757
Background/aim: This study aimed to evaluate the utility of the albumin-bilirubin grade for predicting the prognosis after repeat liver resection for patients with recurrent hepatocellular carcinoma. Patients And Methods: Ninety...
8.
Koizumi A, Komatsu S, Omiya S, Yano Y, Fujishima Y, Ishida J, et al.
Anticancer Res . 2024 Apr; 44(5):2055-2061. PMID: 38677746
Background/aim: The treatment algorithm for systemic therapies for advanced hepatocellular carcinoma (HCC) has changed dramatically; however, the therapeutic landscape for sequential second-line or later-line treatments, including ramucirumab, remains controversial. This...
9.
Ishida J, Toyama H, Asari S, Goto T, Nanno Y, Yoshida T, et al.
Surg Endosc . 2024 Mar; 38(5):2699-2708. PMID: 38528262
Background: Drainage fluid amylase (DFA) is useful for predicting clinically relevant postoperative pancreatic fistula (CR-POPF) after distal pancreatectomy (DP). However, difference in optimal cutoff value of DFA for predicting CR-POPF...
10.
Miyake T, Yanagimoto H, Tsugawa D, Akita M, Asakura R, Arai K, et al.
World J Clin Cases . 2024 Feb; 12(2):276-284. PMID: 38313638
Background: Venous thromboembolism (VTE) is a potentially fatal complication of hepatectomy. The use of postoperative prophylactic anticoagulation in patients who have undergone hepatectomy is controversial because of the risk of...